A solid tumour Car-T first?
Satri-cel is filed for gastric cancer approval in China.
Satri-cel is filed for gastric cancer approval in China.
Astra/Daiichi have trumped Gilead’s Trodelvy with a lung cancer approval.
When your investment case breaks down, why not just do the decent thing?
Ibtrozi breezes through FDA review and gives Nuvation its first approval.
As patritumab-dxd's problems mount, Astra's decision to say no to this project looks smart.